top of page
.png)
Our Partners
.png)
.png)
.png)
LEAP 2025
Bio-convergence, the next technological trend of the 21st century, is a transdisciplinary field that merges engineering and life sciences, set to revolutionize the health-tech industry. Bio-convergence fuses life sciences with different technologies from various fields such as mathematics, engineering, and physical and computational sciences, creating a sum far greater than the total of all its parts and opening the door to unique innovations.
LEAP Vision and Mission:
LEAP empowers entrepreneurs and physicians to explore and create revolutionary solutions to unmet needs in the healthcare ecosystem. Our mission is clear:
Create top-tier, multidisciplinary teams of entrepreneurs, clinicians and technologists from various areas to ideate breakthrough solutions
1
Use the program’s partners to identify industry challenges and opportunities, enabling the participants to focus on relevant unmet needs
2
Validate solutions with leading US experts, investors and entrepreneurs to accelerate commercialization, bringing theory to practice quickly
3
Support the program participants in Venture Creation (KPI of End of Program, and 6 months after)
4
Funded by the Israeli Innovation Authority, Leap’s 2nd cohort will focus on revolutionizing BioConvergence in Israel through a premier ideation program:
Duration: 16 weeks program focused on challenges in Bio tech and drug development
Target Audience: Multidisciplinary teams
Program Components:
Learning - Intro to the Biotech industry
Exploring - Needs screening in BioTech solution development
Creating - Develop technologies for major needs
bottom of page